Sandbox:ap: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 15: Line 15:
{{familytree/end}}
{{familytree/end}}


== Differential diagnosis ==
== [[Differential Cyanosis|Differential]] diagnosis ==
{|
{|
! colspan="4" style="background: #4479BA; text-align: center;" |{{fontcolor|#FFF|Hypoparathyroidism}}
! colspan="4" style="background: #4479BA; text-align: center;" |{{fontcolor|#FFF|Hypoparathyroidism}}
Line 22: Line 22:
! style="background: #4479BA; text-align: center;" |{{fontcolor|#FFF|Clinical features}}
! style="background: #4479BA; text-align: center;" |{{fontcolor|#FFF|Clinical features}}
|-
|-
| colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |'''[[Autoimmune]]'''
| colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Autoimmune
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |'''Autoimmune polyglandular hypoparathyroidism'''
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |Autoimmune polyglandular hypoparathyroidism
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |'''[[Autoimmune polyendocrine syndrome type 1]]'''
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |Autoimmune polyglandular endocrinopathy type 1
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Autosomal recessive]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Autosomal recessive]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Mutation in AIRE gene
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Mutation in AIRE gene
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
*Also known as [[Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome|autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy]] ([[APECED syndrome|APECED]]).
*Also known as autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED).
*Presents with a variable combination of:
*Presents with a variable combination of:
**Failure of the [[Parathyroid gland|parathyroid glands]], [[adrenal cortex]], [[gonads]], [[pancreatic beta cells]], [[gastric parietal cells]], [[thyroid gland]], and [[hepatitis]].
**Failure of the parathyroid glands, adrenal cortex, gonads, pancreatic beta cells, gastric parietal cells, and thyroid gland, and hepatitis
**Chronic [[mucocutaneous]] [[candidiasis]]
**Chronic mucocutaneous candidiasis
**[[Dystrophy]] of [[dental enamel]] and [[nails]], [[alopecia]], [[vitiligo]], and keratopathy.
**Dystrophy of dental enamel and nails, alopecia, vitiligo, and keratopath
|-
|-
| colspan="2" rowspan="7" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Isolated
| colspan="2" rowspan="7" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Isolated
Line 39: Line 39:
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |PTH gene
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |PTH gene
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
*Clinical features of hypocalcemia including:
*Clinical features of hypocalcemia including
**[[Tetany]] (hallmark of acute [[hypocalcemia]]).
**Tetany (hallmark of acute hypocalcemia)
**[[Paresthesia]] in [[fingertips]], [[toes]], and perioral area.
**Paresthesia in fingertips, toes, perioral area
**[[Carpopedal spasm|Carpopedal spasms]].
**Carpopedal spasms
**Circumoral [[numbness]].
**Circumoral numbness
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[GCM2]] gene
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[GCM2]] gene
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
*Clinical features of hypocalcemia including:
*Clinical features of hypocalcemia including
**[[Tetany]] (hallmark of acute [[hypocalcemia]]).
**Tetany (hallmark of acute hypocalcemia)
**[[Paresthesia]] in [[fingertips]], [[toes]], and perioral area.
**Paresthesia in fingertips, toes, perioral area
**[[Carpopedal spasm|Carpopedal spasms]].
**Carpopedal spasms
**Circumoral [[numbness]].
**Circumoral numbness
*[[Dominant negative mutation]].
*[[Dominant negative mutation]]
|-
|-
| rowspan="2" style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Autosomal recessive]]
| rowspan="2" style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Autosomal recessive]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |PTH gene
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |PTH gene
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
*Clinical features of hypocalcemia including:
*Clinical features of hypocalcemia including
**[[Tetany]] (hallmark of acute [[hypocalcemia]]).
**Tetany (hallmark of acute hypocalcemia)
**[[Paresthesia]] in [[fingertips]], [[toes]], and perioral area.
**Paresthesia in fingertips, toes, perioral area
**[[Carpopedal spasm|Carpopedal spasms]].
**Carpopedal spasms
**Circumoral [[numbness]].
**Circumoral numbness
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Glial cell missing 2 ([[GCM2]]) gene<ref name="pmid18712808" />
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[GCM2]] gene<ref name="pmid18712808" />
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
*Clinical features of hypocalcemia including:
*Clinical features of hypocalcemia including
**[[Tetany]] (hallmark of acute [[hypocalcemia]]).
**Tetany (hallmark of acute hypocalcemia)
**[[Paresthesia]] in [[fingertips]], [[toes]], and perioral area.
**Paresthesia in fingertips, toes, perioral area
**[[Carpopedal spasm|Carpopedal spasms]].
**Carpopedal spasms
**Circumoral [[numbness]].
**Circumoral numbness
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[X-linked]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[X-linked]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[FHL1 (gene)|FHL1]] gene (exon 4, c.C283T, p.R95W) on chromosome locus Xq26-q27.
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[FHL1 (gene)|FHL1]] gene (exon 4, c.C283T, p.R95W) on chromosome locus Xq26-q27.
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
*Clinical features of hypocalcemia including:
*Clinical features of hypocalcemia including
**[[Tetany]] (hallmark of acute [[hypocalcemia]]).
**Tetany (hallmark of acute hypocalcemia)
**[[Paresthesia]] in [[fingertips]], [[toes]], and perioral area.
**Paresthesia in fingertips, toes, perioral area
**[[Carpopedal spasm|Carpopedal spasms]].
**Carpopedal spasms
**Circumoral [[numbness]].
**Circumoral numbness
|-
|-
| rowspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Autosomal dominant hypercalcemia
| rowspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Autosomal dominant hypercalcemia
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |Autosomal dominant hypocalcemia type 1
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |Autosomal dominant hypocalcemia type 1
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Autosomal dominant]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Autosomal dominant]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Calcium-sensing receptor]] [[gene mutation]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Calcium-sensing receptor gene mutation
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
*[[Calcium-sensing receptor]] gene activating mutation.
*[[Calcium-sensing receptor|Calcium-sensing]] receptor gene activating mutation.
*'''Most common genetic form''' of hypoparathyroidism.
*'''Most common genetic form''' of hypoparathyroidism.
*Also known as familial hypercalciuric hypocalcemia.
*Also known as familial hypercalciuric hypocalcemia.
*The activating mutation results in gain in function.
*The activating mutation results in gain in function.
*[[Calcium-sensing receptor]] gene activating mutation can also cause mild [[Bartter syndrome]] type 5. This mutation cause the inhibition of apical potassium channel in the thick ascending limb of the [[loop of Henle]] in the [[kidney]].
*Calcium-sensing receptor gene activating mutation can also cause Bartter syndrome type 5.This mutation cause the inhibition of apical potassium channel in the thick ascending limb of the loop of Henle in the kidney.
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |Autosomal dominant hypocalcemia type 2
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |Autosomal dominant hypocalcemia type 2
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Autosomal dominant]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Autosomal dominant]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |G protein G11 ([[GNA11]]) mutation
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |G protein G11 (GNA11) mutation
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
*Clinical features of hypocalcemia including:
*Clinical features of hypocalcemia including
**[[Tetany]] (hallmark of acute [[hypocalcemia]]).
**Tetany (hallmark of acute hypocalcemia)
**[[Paresthesia]] in [[fingertips]], [[toes]], and perioral area.
**Paresthesia in fingertips, toes, perioral area
**[[Carpopedal spasm|Carpopedal spasms]].
**Carpopedal spasms
**Circumoral [[numbness]].
**Circumoral numbness
|-
|-
| colspan="2" rowspan="6" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Congenital multisystem syndromes
| colspan="2" rowspan="6" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Congenital multisystem syndromes
Line 120: Line 120:
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Deletion of the [[TBCE]] gene
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Deletion of the [[TBCE]] gene
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Presents with [[hypoparathyroidism]] due to absent [[Parathyroid gland|parathyroid tissue]], growth retardation, medullary stenosis of tubular bones.
* Presents with [[hypoparathyroidism]] due to absent parathyroid tissue, growth retardation, medullary stenosis of tubular bones.
|-
|-
| colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |'''Kenny-Caffey syndrome type 2'''
| colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |'''Kenny-Caffey syndrome type 2'''
Line 126: Line 126:
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Mutation of “family with sequence similarity 111, member A″ (FAM111A) gene located on chromosome locus 11q12.1
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Mutation of “family with sequence similarity 111, member A″ (FAM111A) gene located on chromosome locus 11q12.1
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Patients with Kenny-Caffey sundrome type 2 have same clinical features as Kenny-Caffey syndrome type 1 except for [[mental retardation]].
* Patients with Kenny-Caffey sundrome type 2 have same clinical features as Kenny-Caffey syndrome type 1 except for mental retardation.
|-
|-
| colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |'''Sanjad-Sakati syndrome'''
| colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |'''Sanjad-Sakati syndrome'''
Line 139: Line 139:
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Mutation|Mutations]] in the [[GATA3]] gene
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Mutation|Mutations]] in the [[GATA3]] gene
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
*Also known as hypoparathyroidism, [[deafness]], and renal dysplasia (HDR) syndrome.
*Also known as hypoparathyroidism, [[deafness]], and renal dysplasia (HDR) syndrome
*Presents with primary hypoparathyroidism, nerve [[deafness]], steroid-resistant [[nephrosis]].
*Presents with primary hypoparathyroidism, nerve [[deafness]], steroid-resistant [[nephrosis]].
|-
|-
Line 148: Line 148:
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | mtDNA deletion
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | mtDNA deletion
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
*Progressive external [[ophthalmoplegia]]
*Progressive external ophthalmoplegia
*[[Retinitis pigmentosa]]
*Retinitis pigmentosa
*[[Cardiomyopathy]]
*Cardiomyopathy
*[[Heart block]]
*Heart block
|-
|-
| colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Maternally inherited diabetes and deafness (MIDD)
| colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Maternally inherited diabetes and deafness (MIDD)
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Mitochondrial inheritence
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Mitochondrial inheritence
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | MT‑TL1 defect
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | MT‑TL1
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
*[[Diabetes mellitus]]
*Diabetes mellitus and deafness
*[[Deafness]]
|-
|-
| rowspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Mitochondrial enzyme deficiencies
| rowspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Mitochondrial enzyme deficiencies
Line 165: Line 164:
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | HADHA or HADHB gene mutation
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | HADHA or HADHB gene mutation
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
*Clinical features of mitochondrial trifunctional protein deficiency occurring '''during''' [[Infancy|'''infancy''']] include:
*Clinical features of mitochondrial trifunctional protein deficiency occurring during infancy include:
**[[Feeding difficulties]]
**Feeding difficulties
**[[Lethargy]]
**Lethargy
**[[Hypoglycemia]]
**Hypoglycemia
**[[Hypotonia]]
**Hypotonia
**[[Liver disease|Liver problems]]
**Liver problems
*[[Infant|Infants]] with mitochondrial trifunctional protein deficiency are also at '''increased risk''' for:  
*Infants with mitochondrial trifunctional protein deficiency are also at increased risk for:  
**Serious [[heart]] problems
**Serious heart problems
**[[Breathing difficulties]]
**Breathing difficulties
**[[Coma]]
**Coma
**[[Sudden death]]
**Sudden death
*Clinical features of mitochondrial trifunctional protein deficiency occurring '''after [[infancy]]''' include:
*Clinical features of mitochondrial trifunctional protein deficiency occurring after infancy include:
**[[Hypotonia]]
**Hypotonia
**[[Muscle pain]]
**Muscle pain
**Breakdown of muscle tissue
**Breakdown of muscle tissue
**[[Peripheral neuropathy]]
**Peripheral neuropathy
|-
|-
| colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency]] ([[LCHAD deficiency]])
| colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency (LCHAD deficiency)
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Autosomal recessive]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Autosomal recessive]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |G1528C gene mutation
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |G1528C gene mutation
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
*Clinical features of [[LCHAD deficiency]] include:
*Clinical features of LCHAD deficiency include:
**[[Hypoglycemia]]
**Hypoglycemia
**[[Hepatopathy]]
**Hepatopathy
**[[Hypotonia]]
**Hypotonia
**[[Cardiomyopathy]]
**Cardiomyopathy
**[[Retinopathy]]
**Retinopathy
|-
|-
| rowspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Heavy metal storage disorders
| rowspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Heavy metal storage disorders
| colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Hemochromatosis
| colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Hemochromatosis
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Autosomal recessive]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Autosomal recessive]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[HFE]] [[gene mutation]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |HFE gene mutation
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
*Early symptoms of [[hereditary hemochromatosis]] are nonspecific and may include:
*Early symptoms of hereditary hemochromatosis are nonspecific and may include:
**[[Fatigue]]
**Fatigue
**[[Arthralgia|Joint pain]]
**Joint pain
**[[Abdominal pain]]
**Abdominal pain
**[[Decreased libido]]
**Decreased libido
*Late stage clinical features may include:
*Late stage clinical features may include:
**[[Arthritis]]
**Arthritis
**[[Liver disease]]
**Liver disease
**[[Diabetes]]
**Diabetes
**[[Heart]] abnormalities
**Heart abnormalities
**[[Skin discoloration]]
**Skin discoloration.
|-
|-
| colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Wilson's disease
| colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Wilson's disease
Line 214: Line 213:
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | ATP7B gene mutation
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | ATP7B gene mutation
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
*Clinical features of [[Wilson's disease]] include:
*Clinical features of Wilson's disease include:
**'''Initial feature'''
**Initial feature
***'''Children and young adults:''' [[Liver disease]]
***Children and young adults: Liver disease
***'''Adults:''' [[Nervous system disease|Nervous system disorders]] and [[Psychiatric Disorders|psychiatric disorders]]
***Adults: nervous system disorders and psychiatric problems
*Other clinical features include:
*Other clinical features include:
**[[Clumsiness]]
**Clumsiness
**[[Tremors]]
**Tremors
**[[Difficulty walking]]
**Difficulty walking
**[[Speech problems]]
**Speech problems
**Impaired thinking ability
**Impaired thinking ability
**[[Depression]]
**Depression
**[[Anxiety]]
**Anxiety
**[[Mood swings]]
**Mood swings.
|}
|}
<references />
<references />

Revision as of 17:07, 3 October 2017

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hypercalcemia
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Related to Parathyroid gland
 
 
 
 
 
 
 
 
 
 
 
Unrelated to parathyroid gland
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Primary hyperparathyroidism
 
 
Secondary hyperparathyroidism
 
 
Tertiary hyperparathyroidism
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Typical primary hyperparathyroidism
 
Familial hypocalciuric hypercalcemia
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Malignancy
 
 
 
 
 
Medication induced
 
 
 
Nutritional
 
 
 
 
Granulomatous disease
 
 
Surgical
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Para-neoplastic syndrome: Parathyroid hormone related peptide
 
Metaplasia: Hypercalcemia due to bone destruction
 
Thiazide diuretics
 
Lithium
 
Milk alkali syndrome
 
Vitamin D toxicity
 
Sarcoidosis
 
 
Immobilization
 

Differential diagnosis

Hypoparathyroidism Inheritance Gene mutation Clinical features
Autoimmune Autoimmune polyglandular hypoparathyroidism Autoimmune polyglandular endocrinopathy type 1 Autosomal recessive Mutation in AIRE gene
  • Also known as autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED).
  • Presents with a variable combination of:
    • Failure of the parathyroid glands, adrenal cortex, gonads, pancreatic beta cells, gastric parietal cells, and thyroid gland, and hepatitis
    • Chronic mucocutaneous candidiasis
    • Dystrophy of dental enamel and nails, alopecia, vitiligo, and keratopath
Isolated Familial Isolated hypoparathyroidism Autosomal dominant PTH gene
  • Clinical features of hypocalcemia including
    • Tetany (hallmark of acute hypocalcemia)
    • Paresthesia in fingertips, toes, perioral area
    • Carpopedal spasms
    • Circumoral numbness
GCM2 gene
  • Clinical features of hypocalcemia including
    • Tetany (hallmark of acute hypocalcemia)
    • Paresthesia in fingertips, toes, perioral area
    • Carpopedal spasms
    • Circumoral numbness
  • Dominant negative mutation
Autosomal recessive PTH gene
  • Clinical features of hypocalcemia including
    • Tetany (hallmark of acute hypocalcemia)
    • Paresthesia in fingertips, toes, perioral area
    • Carpopedal spasms
    • Circumoral numbness
GCM2 gene[1]
  • Clinical features of hypocalcemia including
    • Tetany (hallmark of acute hypocalcemia)
    • Paresthesia in fingertips, toes, perioral area
    • Carpopedal spasms
    • Circumoral numbness
X-linked FHL1 gene (exon 4, c.C283T, p.R95W) on chromosome locus Xq26-q27.
  • Clinical features of hypocalcemia including
    • Tetany (hallmark of acute hypocalcemia)
    • Paresthesia in fingertips, toes, perioral area
    • Carpopedal spasms
    • Circumoral numbness
Autosomal dominant hypercalcemia Autosomal dominant hypocalcemia type 1 Autosomal dominant Calcium-sensing receptor gene mutation
  • Calcium-sensing receptor gene activating mutation.
  • Most common genetic form of hypoparathyroidism.
  • Also known as familial hypercalciuric hypocalcemia.
  • The activating mutation results in gain in function.
  • Calcium-sensing receptor gene activating mutation can also cause Bartter syndrome type 5.This mutation cause the inhibition of apical potassium channel in the thick ascending limb of the loop of Henle in the kidney.
Autosomal dominant hypocalcemia type 2 Autosomal dominant G protein G11 (GNA11) mutation
  • Clinical features of hypocalcemia including
    • Tetany (hallmark of acute hypocalcemia)
    • Paresthesia in fingertips, toes, perioral area
    • Carpopedal spasms
    • Circumoral numbness
Congenital multisystem syndromes DiGeorge syndrome Autosomal dominant 22q11.2 deletion.
CHARGE syndrome Autosomal dominant CHD7 G744S missense mutation
Kenny-Caffey syndrome type 1 Autosomal recessive Deletion of the TBCE gene
  • Presents with hypoparathyroidism due to absent parathyroid tissue, growth retardation, medullary stenosis of tubular bones.
Kenny-Caffey syndrome type 2 Autosomal dominant Mutation of “family with sequence similarity 111, member A″ (FAM111A) gene located on chromosome locus 11q12.1
  • Patients with Kenny-Caffey sundrome type 2 have same clinical features as Kenny-Caffey syndrome type 1 except for mental retardation.
Sanjad-Sakati syndrome Autosomal recessive Mutation in TBCE gene.
Barakat syndrome Autosomal recessive Mutations in the GATA3 gene
  • Also known as hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome
  • Presents with primary hypoparathyroidism, nerve deafness, steroid-resistant nephrosis.
Metabolic diseases Mitochondiral polyneuropathies Kearns–Sayre syndrome Mitochondrial inheritence mtDNA deletion
  • Progressive external ophthalmoplegia
  • Retinitis pigmentosa
  • Cardiomyopathy
  • Heart block
Maternally inherited diabetes and deafness (MIDD) Mitochondrial inheritence MT‑TL1
  • Diabetes mellitus and deafness
Mitochondrial enzyme deficiencies Mitochondrial trifunctional protein deficiency (MTP deficiency) Autosomal recessive HADHA or HADHB gene mutation
  • Clinical features of mitochondrial trifunctional protein deficiency occurring during infancy include:
    • Feeding difficulties
    • Lethargy
    • Hypoglycemia
    • Hypotonia
    • Liver problems
  • Infants with mitochondrial trifunctional protein deficiency are also at increased risk for:
    • Serious heart problems
    • Breathing difficulties
    • Coma
    • Sudden death
  • Clinical features of mitochondrial trifunctional protein deficiency occurring after infancy include:
    • Hypotonia
    • Muscle pain
    • Breakdown of muscle tissue
    • Peripheral neuropathy
Long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency (LCHAD deficiency) Autosomal recessive G1528C gene mutation
  • Clinical features of LCHAD deficiency include:
    • Hypoglycemia
    • Hepatopathy
    • Hypotonia
    • Cardiomyopathy
    • Retinopathy
Heavy metal storage disorders Hemochromatosis Autosomal recessive HFE gene mutation
  • Early symptoms of hereditary hemochromatosis are nonspecific and may include:
    • Fatigue
    • Joint pain
    • Abdominal pain
    • Decreased libido
  • Late stage clinical features may include:
    • Arthritis
    • Liver disease
    • Diabetes
    • Heart abnormalities
    • Skin discoloration.
Wilson's disease Autosomal recessive ATP7B gene mutation
  • Clinical features of Wilson's disease include:
    • Initial feature
      • Children and young adults: Liver disease
      • Adults: nervous system disorders and psychiatric problems
  • Other clinical features include:
    • Clumsiness
    • Tremors
    • Difficulty walking
    • Speech problems
    • Impaired thinking ability
    • Depression
    • Anxiety
    • Mood swings.